1921
Volume 103, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Recent evidence indicates mass drug administration with azithromycin may reduce child mortality. This study uses verbal autopsy (VA) to investigate the causes of individual deaths during the Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance (MORDOR) trial in Malawi. Cluster randomization was performed as part of MORDOR. Biannual household visits were conducted to distribute azithromycin or placebo to children aged 1–59 months and update the census to identify deaths for VA. MORDOR was not powered to investigate mortality effects at individual sites, but the available evidence is presented here for hypothesis generation regarding the mechanism through which azithromycin may reduce child mortality. Automated VA analysis was performed to infer the likely cause of death using two major analysis programs, InterVA and SmartVA. A total of 334 communities were randomized to azithromycin or placebo, with more than 130,000 person-years of follow-up. During the study, there were 1,184 deaths, of which 1,131 were followed up with VA. Mortality was 9% lower in azithromycin-treated communities than in placebo communities (rate ratio 0.91 [95% CI: 0.79–1.05]; = 0.20). The intention-to-treat analysis by cause using InterVA suggested fewer HIV/AIDS deaths in azithromycin-treated communities (rate ratio 0.70 [95% CI: 0.50–0.97]; = 0.03) and fewer pneumonia deaths (rate ratio 0.82 [95% CI: 0.60–1.12]; = 0.22). The use of the SmartVA algorithm suggested fewer diarrhea deaths (rate ratio 0.71 [95% CI: 0.51–1.00]; = 0.05) and fewer pneumonia deaths (rate ratio 0.58 [95% CI: 0.33–1.00]; = 0.05). Although this study is not able to provide strong evidence, the data suggest that the mortality reduction during MORDOR in Malawi may have been due to effects on pneumonia and diarrhea or HIV/AIDS mortality.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.19-0613
2020-04-27
2020-09-22
Loading full text...

Full text loading...

/deliver/fulltext/14761645/103/3/tpmd190613.html?itemId=/content/journals/10.4269/ajtmh.19-0613&mimeType=html&fmt=ahah

References

  1. Emerson PM, Hooper PJ, Sarah V, 2017. Progress and projections in the program to eliminate trachoma. PLoS Negl Trop Dis 11: e0005402.
    [Google Scholar]
  2. Coles CL, Seidman JC, Levens J, Mkocha H, Munoz B, West S, 2011. Association of mass treatment with azithromycin in trachoma-endemic communities with short-term reduced risk of diarrhea in young children. Am J Trop Med Hyg 85: 691696.
    [Google Scholar]
  3. Kigen G, Rotich J, Karimurio J, Rono H, 2014. Collateral benefits arising from mass administration of azithromycin in the control of active trachoma in resource limited settings. Pan Afr Med J 19: 256.
    [Google Scholar]
  4. Sadiq ST, Glasgow KW, Drakeley CJ, Muller O, Greenwood BM, Mabey DC, Bailey RL, 1995. Effects of azithromycin on malariometric indices in The Gambia. Lancet 346: 881882.
    [Google Scholar]
  5. Schachterle SE, Mtove G, Levens JP, Clemens E, Shi L, Raj A, Dumler JS, Munoz B, West S, Sullivan DJ, 2014. Short-term malaria reduction by single-dose azithromycin during mass drug administration for trachoma, Tanzania. Emerg Infect Dis 20: 941949.
    [Google Scholar]
  6. Whitty CJ, Glasgow KW, Sadiq ST, Mabey DC, Bailey R, 1999. Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children. Pediatr Infect Dis J 18: 955958.
    [Google Scholar]
  7. Porco TC, 2009. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial. JAMA 302: 962968.
    [Google Scholar]
  8. See CW, O’Brien KS, Keenan JD, Stoller NE, Gaynor BD, Porco TC, Lietman TM, 2015. The effect of mass azithromycin distribution on childhood mortality: beliefs and estimates of efficacy. Am J Trop Med Hyg 93: 11061109.
    [Google Scholar]
  9. Keenan JD et al., 2018. Azithromycin to reduce childhood mortality in sub-Saharan Africa. N Engl J Med 378: 15831592.
    [Google Scholar]
  10. Gonzalez-Martinez C et al., 2017. Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial. Trials 18: 622.
    [Google Scholar]
  11. Koletar SL, Berry AJ, Cynamon MH, Jacobson J, Currier JS, MacGregor RR, Dunne MW, Williams DJ, 1999. Azithromycin as treatment for disseminated Mycobacterium avium complex in AIDS patients. Antimicrob Agents Chemother 43: 28692872.
    [Google Scholar]
  12. Nichols EK et al., WHO Verbal Autopsy Working Group, 2018. The WHO 2016 verbal autopsy instrument: an international standard suitable for automated analysis by InterVA, InSilicoVA, and Tariff 2.0. PLoS Med 15: e1002486.
    [Google Scholar]
  13. Kalter HD, Perin J, Black RE, 2016. Validating hierarchical verbal autopsy expert algorithms in a large data set with known causes of death. J Glob Health 6: 010601.
    [Google Scholar]
  14. Murray CJL et al., 2014. Using verbal autopsy to measure causes of death: The comparative performance of existing methods. BMC Med 12: 5.
    [Google Scholar]
  15. de Savigny D et al., 2017. Integrating community-based verbal autopsy into civil registration and vital statistics (CRVS): system-level considerations. Glob Health Action 10: 1272882.
    [Google Scholar]
  16. Umeå Centre for Global Health Research, University of Umeå, 2018. InterVA Products. Available at http://www.interva.net/. Accessed October 26, 2018.
  17. Institute for Health Metrics and Evaluation (IHME), 2015. Verbal Autopsy Tools. Available at http://www.healthdata.org/verbal-autopsy/tools. Accessed October 28, 2018.
    [Google Scholar]
  18. Byass P et al., 2012. Strengthening standardised interpretation of verbal autopsy data: the new InterVA-4 tool. Glob Health Action 5: 18.
    [Google Scholar]
  19. Murray CJL et al., 2011. Population health metrics research consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasets. Popul Health Metr 9, 27.
    [Google Scholar]
  20. Serina P et al., 2015. Improving performance of the Tariff Method for assigning causes of death to verbal autopsies. BMC Med 13: 291.
    [Google Scholar]
  21. Serina P et al., 2018. What is the optimal recall period for verbal autopsies? Validation study based on repeat interviews in three populations. Popul Health Metr 14: 40.
    [Google Scholar]
  22. Roth GA et al., 2018. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392: P1736P1788.
    [Google Scholar]
  23. Contopoulos-Ioannidis DG, Ioannidis JP, Chew P, Lau J, 2001. Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for lower respiratory tract infections. J Antimicrob Chemother 48: 691703.
    [Google Scholar]
  24. Guchev I, Gray GC, Klochkov OI, 2004. Two regimens of azithromycin prophylaxis against community-acquired respiratory and skin/soft-tissue infections among military trainees. Clin Infect Dis 38: 10951101.
    [Google Scholar]
  25. Adegbola RA, Mulholland EK, Bailey R, Secka O, Sadiq T, Glasgow K, Mabey D, 1995. Effect of azithromycin on pharyngeal microflora. Pediatr Infect Dis J 14: 335337.
    [Google Scholar]
  26. Lanata CF, Fischer-Walker CL, Olascoaga AC, Torres CX, Aryee MJ, Black RE; Child Health Epidemiology Reference Group of the World Health Organization and UNICEF, 2013. Global causes of diarrheal disease mortality in children <5 years of age: A systematic review. PLoS One 8: e72788.
    [Google Scholar]
  27. Culić O et al., 2002. Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. Eur J Pharmacol 450: 277289.
    [Google Scholar]
  28. Weisz AJ, Manary MJ, Stephenson K, Agapova S, Manary FG, Thakwalakwa C, Shulman RJ, Manary MJ, Abnormal gut integrity is associated with reduced linear growth in rural Malawian children. J Pediatr Gastroenterol Nutr 55: 747750.
    [Google Scholar]
  29. Burr SE, Hart J, Edwards T, Harding-Esch EM, Holland MJ, Mabey DCW, Sillah A, Bailey RL, 2014. Anthropometric indices of Gambian children after one or three annual rounds of mass drug administration with azithromycin for trachoma control. BMC Public Health 14: 1176.
    [Google Scholar]
  30. Doan T et al., 2019. Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution. Nat Med 25: 13701376.
    [Google Scholar]
  31. Keenan JD et al., 2019. Linear growth in preschool children treated with mass azithromycin distributions for trachoma: a cluster-randomized trial. PLoS Negl Trop Dis 13: e0007442.
    [Google Scholar]
  32. Hakim J et al., REALITY Trial Team, 2017. Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa. N Engl J Med 377: 233245.
    [Google Scholar]
  33. Post FA et al., 2018, Causes and timing of mortality and morbidity among late presenters starting antiretroviral therapy in the REALITY trial. Clin Infect Dis 66 (Suppl_2): S132S139.
    [Google Scholar]
  34. Dunne MW, Bozzette S, McCutchan JA, Michael PDubé, Sattler FR, Forthal D, Akemper C, Havlir D; California Collaborative Treatment Group, 1999. Efficacy of azithromycin in prevention of Pneumocystis carinii pneumonia: a randomised trial. Lancet 354: 891895.
    [Google Scholar]
  35. UNAIDS Country Factsheet, 2018. Available at https://www.unaids.org/en/regionscountries/countries/malawi. Accessed August 15, 2019.
  36. Nagoli J, Holvoet K, Remme M, 2010. HIV and AIDS vulnerability in fishing communities in Mangochi district, Malawi. Afr J AIDS Res 9: 7180.
    [Google Scholar]
  37. Hart JD, Edwards T, Burr SE, Harding-Esch EM, Takaoka K, Holland MJ, Sillah A, Mabey DCW, Bailey RL, 2014. Effect of azithromycin mass drug administration for trachoma on spleen rates in Gambian children. Trop Med Int Health 19: 207211.
    [Google Scholar]
  38. Arzika AM et al., 2019. Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: a cluster-randomized, placebo-controlled trial. PLoS Med 16: e1002835.
    [Google Scholar]
  39. West SK, Bloch E, Weaver J, Munoz B, Mrango Z, Kasubi M, Lietman T, Coles C, 2019. Morbidity in a longitudinal cohort of children residing in villages randomized to biannual treatment with azithromycin versus placebo. Clin Infect Dis 70: 574580.
    [Google Scholar]
  40. Chandramohan D et al., 2019. Effect of adding azithromycin to seasonal malaria chemoprevention. N Engl J Med 380: 21972206.
    [Google Scholar]
  41. AbouZahr C, Rampatige R, Lopez A, DeSavigny D, 2012. When civil registration is inadequate: interim methods for generating vital statistics. Pac Health Dialog 18: 215230.
    [Google Scholar]
  42. World Health Organization, 2012. Verbal Autopsy Standards: The 2012 WHO verbal autopsy instrument Release Candidate 1, Geneva, Switzerland: World Health Organization.
  43. World Health Organization, 2013. Verbal Autopsy Standards: Ascertaining and Attributing Causes of Death. Available at http://www.who.int/healthinfo/statistics/verbalautopsystandards/en/. Accessed August 1, 2019.
    [Google Scholar]
  44. McCormick TH, Li ZR, Calvert C, Crampin AC, Kahn K, Clark SJ, 2016. Probabilistic cause-of-death assignment using verbal autopsies. J Am Stat Assoc 111: 10361049.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.19-0613
Loading
/content/journals/10.4269/ajtmh.19-0613
Loading

Data & Media loading...

Supplemental tables

  • Received : 19 Aug 2019
  • Accepted : 11 Feb 2020
  • Published online : 27 Apr 2020
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error